Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec;43(12):6839-6846.
doi: 10.1007/s10072-022-06362-8. Epub 2022 Aug 30.

Occurrence of malignant diseases in patients with multiple sclerosis: population-based MS Registry data

Affiliations

Occurrence of malignant diseases in patients with multiple sclerosis: population-based MS Registry data

Gorica Maric et al. Neurol Sci. 2022 Dec.

Abstract

Introduction: Among different comorbidities occurring in multiple sclerosis (MS), the presence of malignant diseases in these patients is of the particular importance. The aim of this study was to determine the malignant diseases burden in a whole cohort of patients with MS in the Belgrade region, based on the Belgrade population registry data.

Material and methods: This study comprises 2725 MS patients from the MS Registry, which represents a source for all necessary demographic and clinical data. Firstly, the Registry was searched for all persons with MS who had cancer comorbidity, during the period 1996-2019. Diagnosis of cancer was validated by the patients' medical documentation. In order to investigate factors associated with the occurrence of any type of the cancer and/ or breast cancer only, in persons with MS, different logistic regression analyses were performed.

Results: A total of 64 persons with 69 malignant diseases were observed (prevalence 2.53%). The most frequent malignancies in males were skin cancer (50.0%) and in females, breast cancer (23.2%). The cumulative incidence of cancer comorbidity in persons with MS was 324.9 new cases per 100,000 person-years for the total population (137.6/100,000 in males and 403.6 per 100,000 in females). Comparison of cancer incidence rate between MS and general Belgrade population revealed lower risk for malignancy occurrence in the MS population in total (standardized incidence ratio, SIR = 0.58, 95% CI 0.16-1.49).

Conclusions: Our findings demonstrate that MS patients in the Belgrade region have lower risk for the development of malignancy than age- and sex-matched general population.

Keywords: Cancer; Multiple sclerosis; Risk factors; SIR.

PubMed Disclaimer

References

    1. Coetzee T, Thompson AJ (2020) Atlas of MS 2020: Informing global policy change. Mult Scler 26:1807–1808. https://doi.org/10.1177/1352458520968811 - DOI - PubMed
    1. Hobart J, Bowen A, Pepper G, Crofts H, Eberhard L, Berger T, Boyko A, Boz C, Butzkueven H, Celius EG, Drulovic J, Flores J, Horáková D, Lebrun-Frénay C, Marrie RA, Overell J, Piehl F, Rasmussen PV, Sá MJ, Sîrbu CA, Skromne E, Torkildsen Ø, van Pesch V, Vollmer T, Zakaria M, Ziemssen T, Giovannoni G (2019) International consensus on quality standards for brain health-focused care in multiple sclerosis. Mult Scler 25:1809–1818. https://doi.org/10.1177/1352458518809326 - DOI - PubMed
    1. Marrie RA, Maxwell C, Mahar A, Ekuma O, McClintock C, Seitz D, Webber C, Groome PA (2021) Cancer incidence and mortality rates in multiple sclerosis: a matched cohort study. Neurology 96:e50–e512. https://doi.org/10.1212/WNL.0000000000011219 - DOI
    1. Marrie RA, Elliott L, Marriott J, Cossoy M, Blanchard J, Leung S, Yu N (2015) Effect of comorbidity on mortality in multiple sclerosis. Neurology 85:240–247. https://doi.org/10.1212/WNL.0000000000001718 - DOI - PubMed - PMC
    1. Valderas JM, Starfield B, Sibbald B, Salisbury C, Roland M (2009) Defining comorbidity: implications for understanding health and health services. Ann Fam Med 7:357–363. https://doi.org/10.1370/afm.983 - DOI - PubMed - PMC

LinkOut - more resources